Doxorubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Iron Sucrose Manufacturers of Iron Sucrose Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Iron Sucrose's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 60 to 75 mg/sq.meter68 (67.5)As recommended.IVEvery 3rd Week, or As Required Paedriatic Dosage (20kg) 60 to 90 mg/sq.meter75 (75)As recommended.IV InfusionOver 96 Hours, every 3-4 weeks Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Iron Sucrose is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Iron Sucrose Back to top Manufacturers of Doxorubicin (HCl) in Pakistan A.J.Mirza Al-Habib Atco Bio Pharma CCL Ferozson Pfizer Pharmedic Scharper Turner Umair Back to top Previous Drug Generic - Next Drug Generic
Doxorubicin (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Iron Sucrose Manufacturers of Iron Sucrose Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Iron Sucrose's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 60 to 75 mg/sq.meter68 (67.5)As recommended.IVEvery 3rd Week, or As Required Paedriatic Dosage (20kg) 60 to 90 mg/sq.meter75 (75)As recommended.IV InfusionOver 96 Hours, every 3-4 weeks Neonatal Dosage (3kg) No data regarding the neonatal dosage details of Iron Sucrose is available. High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Iron Sucrose Back to top Manufacturers of Doxorubicin (HCl) in Pakistan A.J.Mirza Al-Habib Atco Bio Pharma CCL Ferozson Pfizer Pharmedic Scharper Turner Umair Back to top Previous Drug Generic - Next Drug Generic